The European Alliance of Associations for Rheumatology (EULAR) Recommends Considering Apos® for Knee and Hip Osteoarthritis Management
The European Alliance of Associations for Rheumatology (EULAR) has updated its guidelines for the non-pharmacological management of hip and knee osteoarthritis (OA) based on an extensive
Apos Recognized by NICE & NHS England’s MedTech Funding Mandate Policy as a Cost-Saving Solution in Knee Osteoarthritis
AposHealth, a leader in non-invasive knee osteoarthritis treatment with its flagship Apos®, has achieved significant recognition, underscoring its commitment to innovative, clinically effective, and cost-saving
AposHealth® Appoints Ben Feldman as Chief Marketing Officer to Lead The Next Phase of Growth
Ben Feldman, M.Med.Sc., with his extensive international healthcare background and expertise in performance and brand marketing, will spearhead AposHealth’s efforts to accelerate growth and expand
Apos® Demonstrates 43% Reduction in Healthcare Utilization and Costs for Patients with Knee and Back Pain
A recent study published in the Journal of Healthcare Economics Outcomes Research1 highlights the substantial impact of Apos® on healthcare resource utilization (HCRU) in patients
AposHealth®’s Breakthrough Hip Osteoarthritis Patient Study Shows 80% of Patients Avoid Joint Replacement Surgery for Up to Five Years
We’re thrilled to announce a significant milestone in the realm of orthopedic care: AposHealth®’s groundbreaking research has been accepted for publication in the esteemed Journal
Apos® Study Reveals: 87% of Apos®-Treated Patients With Knee OA Did Not Pursue Further Surgical Treatment at 5 Years
Apos® Study Reveals 87% of Apos® treated patients who suffer from knee osteoarthritis did not need to pursue further surgical treatment at 5 years.
AposHealth® Honored with Prestigious Innovations Award from PBGH, an organization dedicated to enhancing healthcare quality and affordability for employees
AposHealth®, a global leader in musculoskeletal (MSK) solutions, has been recognized with the award from the Pittsburgh Business Group on Health (PBGH) at the 2023
Apos® Selected as the First Technology Supported by NHS England’s MedTech Funding Mandate for 2024/25
AposHealth® a disruptive global company focused on revolutionising the treatment of musculoskeletal (MSK) conditions such as knee osteoarthritis (OA) is delighted to announce that its
AposHealth®’s Breakthrough Study Shows 89% of Eligible Total Knee Replacement Patients Avoid Surgery for Up to 6 Years with Apos®
AposHealth®, a pioneering healthcare company specializing in innovative non-surgical musculoskeletal interventions, is proud to announce results of a clinical study that demonstrates an impressive 89%
The Honorable David Shulkin M.D., Ninth Secretary, US Department of Veteran Affairs, Joins AposHealth® Board
AposHealth®, a pioneering healthcare technology company specializing in innovative solutions for chronic musculoskeletal pain, is pleased to announce the appointment of Dr. David Shulkin as
NICE recommends Apos® for people with knee osteoarthritis
AposHealth was awarded official guidance for the recommended use of its flagship product Apos® by The National Institute for Health and Care Excellence (NICE).
Apos®, a Non-Invasive Knee Treatment, Proven to Delay Surgery According to a Real-World Study
A recent study on Apos®, a medical device that treats chronic knee conditions, could have significant implications on the cost, pain, and quality-of-life problems associated
AposHealth® Awarded Five-Year Federal Supply Schedule Contract by the Department of Veterans Affairs
Coverage for AposHealth’s revolutionary non-invasive treatment for knee osteoarthritis is now available to federal agencies including the U.S. Department of Veterans Affairs which serves more
Introducing the New Apos®: Designed for Better Style, Comfort, and Precision
AposHealth®‘s next major advance in our mission to create the best patient-centric orthopedic solutions available has arrived. We’ve reimagined the foot-worn device component of our
AposHealth® Partners with TalarMade to Distribute Flagship Product Throughout the UK
AposHealth®, a global leader in the identification and treatment of gait-related conditions, has partnered with TalarMade, a European-based provider of orthotics, podiatry, rehab, and physical
New Research Validates the Smartphone-Based Clinical Gait Assessment Technology Being Used with Apos®
Big news for the future of mobility performance and AposHeath®, as research findings recently published in the journal Gait & Posture demonstrate that OneStep—an innovative,
Summary of Clinical Evidence Supporting Apos® Based on Over 50 Published Peer-Reviewed Articles
A review published by two department chairs, summarizes the clinical evidence of Apos® for the first time. The article authors explain how biomechanical manipulation of
AposHealth® Grabs Attention of European Market with Flagship Solution, Apos®
AposHealth’s flagship solution, Apos®, recently received a significant distinction in Europe in a Medtech Innovation Briefing (MIB) published by the National Institute for Health and
Easily Accessible Smartphone App Provides Gait Measurements Similar to Pressure-Sensor Walkway
Smartphone app validated as tool for gait assessment in clinics. Fifty-five patients with knee, lower back, and hip pain participated in a study that compared
AposHealth® Taps Cheri Lin as Chief Marketing Officer as Growth Surges
Lin’s extensive leadership experience expected to expand use of AposHealth’s revolutionary non-invasive treatment for knee pain nationwide NEW YORK, Feb. 2, 2022 –Disruptive healthcare provider,
Geisinger launches innovative, non-invasive treatment option for patients with knee pain
DANVILLE, Pa. – Geisinger, in partnership with AposHealth, today announced that a new non-invasive, drug-free treatment for patients suffering knee pain from osteoarthritis will be
AposHealth® Appoints New CTO to Accelerate Technological Innovation in the Next Stage of Growth
Rachel Yesharim joins the company’s executive team to help build AposIQ® – a new business unit applying cutting edge technology and data science to inform gait-related treatments. AposHealth®, a global leader in the
A Revolutionary Approach to Using Gold Standard Patient-Reported Outcome Measures in Clinical Practice
A study that was done in collaboration between Montefiore Medical Center and the Apos Israel research group is already influencing the way medical treatments are measured in clinical practice. The study aimed to develop a questionnaire to assess patients, based on
“WALK FAST, LIVE LONGER” AposHealth® CEO Featured on The Live Long and Master Aging Podcast
If you’re a fast walker, you’re likely to live longer. The correlation between walking speed and lifespan has been widely studied and is a good
HealthCare Partners Expands Relationship with AposHealth® to Bring an Innovative, Non-Invasive Treatment for Knee Osteoarthritis to Members Through a New Delivery Model
HealthCare Partners (HCP) today announced an expansion of its partnership with AposHealth® to bring an innovative, non-invasive treatment for knee osteoarthritis currently offered to its
AposHealth® Awarded Research Grant to Support Rebuilding Efforts in the United Kingdom
Healthcare company joins Innovate UK’s efforts to address the effects of COVID-19 LONDON, Jan. 04, 2021 (GLOBE NEWSWIRE) — AposHealth®, a global leader in the identification
Highmark Health Collaborates with AposTherapy to Offer Innovative, Non-Invasive Treatment to Highmark Health Plan Members with Knee Pain
PITTSBURGH and NEW YORK (Dec. 7, 2020) — Highmark Health, a leading national blended health organization, today announced that it is working with AposTherapy to
Dr. David B. Nash Joins the AposHealth® Advisory Board
AposHealth is thrilled to announce that Dr. David B. Nash is joining our advisory board. David B. Nash, MD, MBA, is the Founding Dean Emeritus — and remains on the full-time faculty as the
AposHealth® CEO Dr. Cliff Bleustein, MD, MBA Featured on Medical Device Made Easy Podcast
AposHealth President & CEO Dr. Cliff Bleustein, MD, MBA, recently shared his experience and advice related to the process of placing a medical device on
Healthcare Global Discusses AposHealth® as a Treatment for MSK Pain Without Surgery or Drugs
A new foot-worn device is helping people improve painful musculoskeletal conditions without having to leave their homes or experience invasive treatments. AposHealth® has been developed
Abstract Book Highlights Over 50 Peer-Reviewed Research Papers About Apos®
Available for download, this abstract book presents the extensive scientific evidence that was done independently and in collaboration with our research team. The book is
Healthfirst New York Formalizes Coverage of an Innovative Therapy Called AposHealth® Designed for Use in Orthopedic Conditions
Developed by experts in orthopedics and sports medicine, the AposHealth® foot-worn device is FDA-cleared for treating knee osteoarthritis and a non-FDA cleared wellness device which
Keeping It Short and Simple – A New, Condensed Questionnaire to Assess Patient Severity, Pain, and Function
Asking the most relevant questions to assess patient status is an important step in the translation of scientific methods to clinical practice. In this study,
New Research Shows AposHealth® Significantly Reduces Osteoarthritis Knee Pain
Osteoarthritis is a major cause of pain and disability worldwide, and the knee is the most commonly affected weight-bearing joint among individuals living with the
Apos®’ Efficacy Validated in UK Study According to Pain Reduction, Functional Improvement, Quality of Life, and Velocity Measurements
A study of 455 patients with knee osteoarthritis demonstrated that Apos® improves gait pattern, pain, function, and quality of life within 3 to 6 months.
May 2020 Study Published in JAMA Shows Knee OA Patients Treated with Apos® Experienced Significant Pain Reduction
An independent double-blind RCT study published in May 2020 by the Journal of the American Medical Association showed that 92% of the patients treated with
Research published in The Journal of the American Medical Association (JAMA) Shows Knee Osteoarthritis Patients Treated with AposHealth® Experienced Significant Pain Reduction
May 18, 2020 10:40 ET | Source: AposHealth Leading musculoskeletal physicians, including David Felson, MD, MPH, Stephan Reichenbach, MD, MSc, and Peter Jüni, MD, conducted an independent,
Apos Medical Assets LTD partners with Spirit Access to decrease the cost of knee pain treatments in the UK
Global medical device company Apos Medical Assets, and market access consultancy Spirit Access, are partnering to help CCGs and NHS Trusts improve health outcomes with
AposHealth® Expands Partnership With Professional Physical Therapy to Offer Its Drug-Free Solution to Knee and Low Back Pain Patients at Additional Massachusetts Locations
BOSTON, March 12, 2020 (GLOBE NEWSWIRE) — AposHealth® has strengthened its partnership with Professional Physical Therapy to bring a non-invasive, drug-free alternative to surgery to additional Massachusetts
AposHealth® Partners With Three Physical Therapy Providers in Queens to Bring a Non-Surgical, Drug-Free Solution to Knee and Lower Back Pain Sufferers in New York
Queens, N.Y., March 04, 2020 (GLOBE NEWSWIRE) — AposHealth® has partnered with three local physical therapy providers to bring New York residents suffering from knee
AposHealth® and Ahava Medical & Rehabilitation Center are partnering to bring Brooklyn residents suffering from knee and lower back pain a non-invasive, drug-free alternative to surgery.
Brooklyn, N.Y., Feb. 26, 2020 (GLOBE NEWSWIRE) — AposHealth® and Ahava Medical & Rehabilitation Center have partnered to bring Brooklyn residents suffering from knee and
AposHealth® Launches Unique Patient Activation Program
NEW YORK, Feb. 19, 2020 (GLOBE NEWSWIRE) — AposHealth® and GoMo Health launched the AposHealth® Concierge Care Program, a virtual care coordinator that guides patients
Apos Medical Assets Ltd. Announces $11 Million Series A Extension Funding Round Led by Existing Shareholders
NEW YORK, Feb. 17, 2020 (GLOBE NEWSWIRE) — Apos Medical Assets Ltd.—a global medical device company operating in the US, UK, and Israel —announced today
Study Finds Apos® to Improve the Clinical Measures of Hip Osteoarthritis Patients
A study that examined the effect of AposHealth® on subjects with hip osteoarthritis found that it improved their function, quality of life and hip biomechanics…
Patients with Chronic Low Back Pain Reach Healthy Gait Patterns After 6 Months of Apos®
A clinical study examined the effect of 6 months of AposHealth® treatment on a group of subjects suffering from chronic non-specific low back pain…
